Sarah Stabler

1.0k total citations
23 papers, 485 citations indexed

About

Sarah Stabler is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Sarah Stabler has authored 23 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Sarah Stabler's work include Bacterial Identification and Susceptibility Testing (5 papers), Streptococcal Infections and Treatments (4 papers) and Sepsis Diagnosis and Treatment (3 papers). Sarah Stabler is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Streptococcal Infections and Treatments (4 papers) and Sepsis Diagnosis and Treatment (3 papers). Sarah Stabler collaborates with scholars based in Canada, France and United States. Sarah Stabler's co-authors include Aaron M Tejani, Rodrigue Dessein, Rémi Le Guern, Éric Kipnis, Douglas M Salzwedel, Teddy Grandjean, Philippe Gosset, Matthew P. Cheng, Emmanuel Faure and Chelsea Caya and has published in prestigious journals such as Nature Communications, Annals of Internal Medicine and Cochrane Database of Systematic Reviews.

In The Last Decade

Sarah Stabler

22 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Stabler Canada 10 129 91 89 86 85 23 485
Pablo Vidal Spain 13 152 1.2× 84 0.9× 78 0.9× 103 1.2× 48 0.6× 55 622
Miia Valkonen Finland 12 122 0.9× 108 1.2× 39 0.4× 47 0.5× 179 2.1× 27 909
Lien Vo United States 15 143 1.1× 69 0.8× 111 1.2× 119 1.4× 209 2.5× 38 966
George Delgado United States 10 197 1.5× 60 0.7× 60 0.7× 136 1.6× 101 1.2× 17 754
Verena Schneider‐Lindner Germany 11 109 0.8× 48 0.5× 49 0.6× 44 0.5× 20 0.2× 23 309
Rachel M. Kenney United States 15 230 1.8× 38 0.4× 56 0.6× 172 2.0× 185 2.2× 74 805
Omender Singh India 12 229 1.8× 43 0.5× 54 0.6× 17 0.2× 58 0.7× 53 575
Anil Kumar Saxena Saudi Arabia 19 227 1.8× 110 1.2× 46 0.5× 53 0.6× 38 0.4× 84 936
Maria de Fátima Fernandes Vattimo Brazil 13 79 0.6× 107 1.2× 52 0.6× 19 0.2× 42 0.5× 66 619
Nele Peersman Belgium 9 85 0.7× 65 0.7× 60 0.7× 49 0.6× 78 0.9× 14 409

Countries citing papers authored by Sarah Stabler

Since Specialization
Citations

This map shows the geographic impact of Sarah Stabler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Stabler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Stabler more than expected).

Fields of papers citing papers by Sarah Stabler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Stabler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Stabler. The network helps show where Sarah Stabler may publish in the future.

Co-authorship network of co-authors of Sarah Stabler

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Stabler. A scholar is included among the top collaborators of Sarah Stabler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Stabler. Sarah Stabler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stabler, Sarah, Sébastien Sanges, Louis Terriou, et al.. (2025). Diagnosis, Characteristics, and Outcome of Selective Anti-polysaccharide Antibody Deficiencies In A Retrospective Cohort of 55 Adult Patients. Journal of Clinical Immunology. 45(1). 82–82.
2.
Mitra, Anish R., et al.. (2024). Outcomes Associated with the use of High Dose Corticosteroids and IL-6 Inhibitors for the Treatment of Acute Respiratory Distress Syndrome Secondary to SARS COV-2. Journal of Intensive Care Medicine. 40(4). 388–395. 1 indexed citations
3.
Guern, Rémi Le, Teddy Grandjean, Sarah Stabler, et al.. (2023). Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection. Nature Communications. 14(1). 78–78. 42 indexed citations
4.
5.
Stabler, Sarah, Olivier Paccoud, Marie‐Aude Piot, et al.. (2022). Prevalence of Antimicrobial Resistance and Infectious Diseases in a Hospitalised Migrant Population in Paris, France, a Retrospective Study. International Journal of Public Health. 67. 1604792–1604792. 7 indexed citations
6.
Guern, Rémi Le, Sarah Stabler, Philippe Gosset, et al.. (2021). Colonization resistance against multi-drug-resistant bacteria: a narrative review. Journal of Hospital Infection. 118. 48–58. 23 indexed citations
7.
Stabler, Sarah, et al.. (2021). Closing the Brief Case: Mycoplasma hominis Extragenital Abscess. Journal of Clinical Microbiology. 59(4). 2 indexed citations
8.
Stabler, Sarah, et al.. (2021). The Brief Case: Mycoplasma hominis Extragenital Abscess. Journal of Clinical Microbiology. 59(4). 9 indexed citations
9.
Stabler, Sarah, et al.. (2020). Use of fibrinogen concentrate for trauma-related bleeding: A systematic-review and meta-analysis. The Journal of Trauma: Injury, Infection, and Critical Care. 89(6). 1212–1224. 25 indexed citations
10.
Stabler, Sarah, Marie Titécat, Florent Wallet, et al.. (2020). Clinical relevance of Clostridium bacteremia: An 8-year retrospective study. Anaerobe. 63. 102202–102202. 18 indexed citations
11.
Stabler, Sarah, et al.. (2020). Management of delirium in a medical and surgical intensive care unit. Journal of Clinical Pharmacy and Therapeutics. 46(3). 669–676. 6 indexed citations
12.
Patel, Arpita, et al.. (2020). Vasopressin for Septic Shock in a Medical-Surgical Intensive Care Unit. The Canadian Journal of Hospital Pharmacy. 73(3). 209–215. 1 indexed citations
13.
Cheng, Matthew P., Robert Stenstrom, Katryn Paquette, et al.. (2019). Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis. Annals of Internal Medicine. 1 indexed citations
14.
Masson, Sarah, et al.. (2017). Eplerenone for hypertension. Cochrane Database of Systematic Reviews. 2017(2). CD008996–CD008996. 34 indexed citations
15.
Stabler, Sarah, et al.. (2016). Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit. Journal of Clinical Pharmacy and Therapeutics. 41(6). 730–732. 8 indexed citations
16.
Stabler, Sarah, et al.. (2016). Should Developed Countries, Including Canada, Provide Universal Access to Essential Medications through a National, Publicly Funded and Administered Insurance Plan?. The Canadian Journal of Hospital Pharmacy. 69(2). 167–70. 4 indexed citations
17.
Stabler, Sarah, et al.. (2012). Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients. Cochrane Database of Systematic Reviews. 2012(8). CD007653–CD007653. 61 indexed citations
18.
Stabler, Sarah & Mary H. H. Ensom. (2011). Extended-Interval Aminoglycoside Therapy for Adult Patients with Febrile Neutropenia: A Systematic Review. The Canadian Journal of Hospital Pharmacy. 64(3). 182–91. 4 indexed citations
19.
Tejani, Aaron M, et al.. (2011). Hydralazine for essential hypertension. Cochrane Database of Systematic Reviews. CD004934–CD004934. 50 indexed citations
20.
Stabler, Sarah, et al.. (2010). Spironolactone for hypertension. Cochrane Database of Systematic Reviews. CD008169–CD008169. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Vidal Breakdown of academic impact, for papers by Miia Valkonen Breakdown of academic impact, for papers by Lien Vo Breakdown of academic impact, for papers by George Delgado Breakdown of academic impact, for papers by Verena Schneider‐Lindner Breakdown of academic impact, for papers by Rachel M. Kenney Breakdown of academic impact, for papers by Omender Singh Breakdown of academic impact, for papers by Anil Kumar Saxena Breakdown of academic impact, for papers by Maria de Fátima Fernandes Vattimo Breakdown of academic impact, for papers by Nele Peersman
Rankless by CCL
2026